The buy now, pay later company benefits from a powerful tailwind lifting the industry.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA31 Aug 2025, 21:45 UTC
AI-generated source summary
Affirm's stock recently pleased investors, increasing by 11% after quarterly financials were released, affirming a buy rating in 2025. The stock has risen 42% year-to-date. The video reviews Affirm's quarterly financial results, mentioning that Affirm has 377,000 active merchants, which is up 24% year-over-year and transaction frequency is up 20% over the same time. The expansion of active merchants attracts more consumers into signing up. In fiscal year 2025, the management team hit their profitability target. Revenue per employee is around $1.5 million and gross merchandise volume grew 43% to $10.4 billion. Additionally, Affirm's active cardholder count has doubled to 2.3 million, increasing Affirm's card attach rate to 10%. Intrinsic value calculated is at $66.94 per share, while the stock trades at a forward P/E of 39.9. The analysis reinterates a buy rating.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
